Skip to main content
Microbot Medical Inc. logo

Microbot Medical Inc. — Investor Relations & Filings

Ticker · MBOT ISIN · US59503A2042 LEI · 549300AEUNO16KTJXD72 US Manufacturing
Open in API
Filings indexed 1,062 across all filing types
Latest filing 2021-01-07 Regulatory Filings
Country US United States of America
Listing US MBOT

About Microbot Medical Inc.

http://www.microbotmedical.com/

Microbot Medical Inc. is a commercial-stage medical device company focused on transforming endovascular procedures with advanced robotic technology. The company researches, designs, and develops robotic endoluminal surgery devices for the minimally invasive surgery market. Its flagship product, the LIBERTY® Endovascular Robotic System, is the first single-use, remotely operated robotic solution designed to provide physicians with enhanced precision, control, and efficiency. Developed in collaboration with experts in Interventional Radiology, Neuroradiology, and Cardiology, the system aims to improve patient care and physician safety.

Recent filings

Filing Released Lang Actions
Regulatory Filings 2021
Regulatory Filings Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce unscheduled material events or corporate changes. The text indicates that the company is announcing a Regulation FD Disclosure about the CEO presenting at investor conferences, including details about the presentation dates and availability of videos. There is no substantive financial data or detailed financial statements included. The document also includes a press release as an exhibit, but the main content is an announcement of an event and related disclosures. The document length is 4576 characters, which is relatively short and consistent with an announcement rather than a full report. Therefore, this filing is best classified as a Regulatory Filing (RNS), which is the fallback category for miscellaneous SEC filings like Form 8-K that do not fit other specific categories.
2021-01-07 English
Regulatory Filings 2020
Regulatory Filings
2020-12-07 English
Regulatory Filings 2020
Regulatory Filings Classification · 95% confidence The document is a letter addressed to the SEC requesting acceleration of the effective date of a Registration Statement on Form S-3. It is a formal correspondence related to a securities registration process, not a financial report or earnings release. The document is short (1565 characters) and does not contain financial data or detailed report content. It is a regulatory filing related to securities registration and procedural matters, fitting best under the Regulatory Filings (RNS) category as a formal communication with the SEC.
2020-12-03 English
Regulatory Filings 2020
Regulatory Filings Classification · 90% confidence The provided document text appears to be encoded or encrypted and does not contain any readable content, keywords, regulatory headers, or references to specific report types, fiscal periods, or regulatory bodies. There is no indication of the document being a report itself or an announcement of a report. Due to the lack of identifiable information and the fallback rule for documents that do not fit any specific category, the most appropriate classification is Regulatory Filings (RNS). The document length is 15,000 characters, which is substantial, but without readable content, it cannot be classified as a financial or other specific report type.
2020-12-02 English
Capital/Financing Update 2020
Capital/Financing Update Classification · 100% confidence The document is a Form S-3 Registration Statement filed with the SEC under the Securities Act of 1933. It is a registration statement for the offering of securities, including common stock, preferred stock, warrants, debt securities, rights, and units, with a maximum aggregate offering price of $75,000,000. The document includes a prospectus describing the general terms of the securities to be offered and the manner of offering. It is not a financial report, earnings release, or management discussion, but rather a capital raising filing. The document is lengthy (15,000 characters) and contains detailed registration and offering information, consistent with a Capital/Financing Update filing. Therefore, the appropriate classification is Capital/Financing Update (CAP).
2020-11-25 English
Regulatory Filings 2020
Regulatory Filings Classification · 95% confidence The document is a Form S-8 Registration Statement filed with the SEC by Microbot Medical Inc. on November 25, 2020. Form S-8 is used for registering securities to be offered to employees under employee benefit plans, such as stock option plans or omnibus performance award plans. The document includes details about the securities to be registered, incorporation by reference of prior filings (10-K, 10-Q, 8-K), indemnification provisions, and exhibits related to the plan. It is not an annual report, earnings release, or any other financial report but a registration statement for securities issuance under an employee plan. This type of filing is a regulatory filing but does not fit into the other more specific categories. Therefore, it should be classified as Regulatory Filings (RNS). The document length is substantial (15,000 characters), and it is not merely an announcement or certification, so RNS is appropriate rather than RPA or other categories.
2020-11-25 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.